Michele Emdin
Emdin, Michele
Emdin, Michele, 1958-....
VIAF ID: 73293716 (Personal)
Permalink: http://viaf.org/viaf/73293716
Preferred Forms
- 200 _ 1 ‡a Emdin ‡b , Michele
-
- 100 1 _ ‡a Emdin, Michele
-
-
- 100 1 _ ‡a Emdin, Michele
- 100 1 _ ‡a Emdin, Michele ‡d 1958-
-
- 100 1 _ ‡a Emdin, Michele, ‡d 1958-....
- 100 0 _ ‡a Michele Emdin
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Amiloidosi cardiaca : come si diagnostica, come si cura / Michele Emdin, Giuseppe Vergaro, Claudio Passino | |
The Breathless Heart : Apneas in Heart Failure | |
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy | |
Galectin-3 and aldosterone profibrotic pathways in the failing heart | |
Gamma-glutamyltransferase fractions in human plasma and bile: characteristic and biogenesis | |
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction. | |
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias | |
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? | |
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia | |
Heart, kidney and FGF23: Les liaisons dangereuses. | |
High-Sensitivity Troponins and Prognosis in Heart Failure: Which Kind of Meta-Analysis Is Needed? | |
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? | |
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. | |
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure. | |
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. | |
Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure | |
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox | |
Longer sleep duration and poor sleep quality as risk factors for hyperlipidaemia | |
Low-Thrombogenicity Mechanical Heart Valves: Which Antithrombotic Strategy? | |
Low triiodothyronine and exercise capacity in heart failure | |
Management of complications of cardiac amyloidosis: 10 questions and answers | |
Markers of arrhythmogenic risk in hypertensive subjects. | |
Markers of fibrosis, inflammation, and remodeling pathways in heart failure. | |
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure | |
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. | |
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis | |
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. | |
Myocardial fibrosis as a early cardiac marker of disease in patients with lamin A/C mutations. | |
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. | |
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease. | |
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives. | |
Natriuretic peptide testing in primary care patients. | |
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. | |
Natriuretic peptides. D'où venons-nous? Que sommes-nous? Où allons-nous? | |
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. | |
Natriuretic peptides : the hormones of the heart / Aldo Clerico, Michele Emdin (eds) ; foreword by Luigi Donato | |
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease. | |
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart. | |
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure | |
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies | |
The paradox of low BNP levels in obesity | |
Plasma adrenomedullin relation with Doppler-derived dP/dt in patients with congestive heart failure. | |
Polymorphisms in the eNOS gene and the risk of coronary artery disease: Making the case for genome-wide association studies | |
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators | |
The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). | |
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group. | |
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure. | |
Prognostic value of plasma renin activity in heart failure. | |
Recommendations for the clinical use of cardiac natriuretic peptides | |
Renin profiling predicts neurohormonal response to sacubitril/valsartan | |
Reply | |
Scompenso cardiaco e sistema neuroendocrino / Michele Emdin, Giorgio Iervasi | |
The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis | |
The search for efficient diagnostic and prognostic biomarkers of heart failure. | |
Sex-related differences in chronic heart failure. | |
The significance of serum gamma-glutamyltransferase in cardiovascular diseases | |
Silent myocardial damage in cocaine addicts. | |
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T | |
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica ( | |
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction | |
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches | |
Targeting social disadvantage to prevent early development of heart failure | |
Therapies for cardiac light chain amyloidosis: An update | |
Treating chemoreflex in heart failure: modulation or demolition? | |
Underprescription of disease-modifying drugs in chronic heart failure: More is better? | |
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis | |
Upright Cheyne-Stokes Respiration in Patients With Heart Failure | |
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure. | |
Validity of transit time-based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers | |
Vite sospese : 1938: Università ed ebrei a Pisa / [a cura di] Michele Emdin, Barbara Henry, Ilaria Pavan | |
Voies profibrotique de l'aldosterone et de la galectine-3 dans l'insuffisance cardiaque. | |
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure | |
প্রত্যুত্তর |